Mycobacterial cell wall: structure and role in natural resistance to antibiotics
- PMID: 7988876
- DOI: 10.1111/j.1574-6968.1994.tb07194.x
Mycobacterial cell wall: structure and role in natural resistance to antibiotics
Abstract
Mycobacteria show a high degree of intrinsic resistance to most antibiotics and chemotherapeutic agents. The low permeability of the mycobacterial cell wall, with its unusual structure, is now known to be a major factor in this resistance. Thus hydrophilic agents cross the cell wall slowly because the mycobacterial porin is inefficient in allowing the permeation of solutes and exists in low concentration. Lipophilic agents are presumably slowed down by the lipid bilayer which is of unusually low fluidity and abnormal thickness. Nevertheless, the cell wall barrier alone cannot produce significant levels of drug resistance, which requires synergistic contribution from a second factor, such as the enzymatic inactivation of drugs.
Similar articles
-
Drug sensitivity and environmental adaptation of mycobacterial cell wall components.Trends Microbiol. 1996 Jul;4(7):275-81. doi: 10.1016/0966-842x(96)10031-7. Trends Microbiol. 1996. PMID: 8829336 Review.
-
Cellular impermeability and uptake of biocides and antibiotics in gram-positive bacteria and mycobacteria.Symp Ser Soc Appl Microbiol. 2002;(31):46S-54S. Symp Ser Soc Appl Microbiol. 2002. PMID: 12481828 Review.
-
Recent observations concerning structure and function relationships in the mycobacterial cell envelope: elaboration of a model in terms of mycobacterial pathogenicity, virulence and drug-resistance.Res Microbiol. 1991 May;142(4):464-76. doi: 10.1016/0923-2508(91)90121-p. Res Microbiol. 1991. PMID: 1871434 Review. No abstract available.
-
The envelope of mycobacteria.Annu Rev Biochem. 1995;64:29-63. doi: 10.1146/annurev.bi.64.070195.000333. Annu Rev Biochem. 1995. PMID: 7574484 Review.
-
Fluidity of the lipid domain of cell wall from Mycobacterium chelonae.Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):11254-8. doi: 10.1073/pnas.92.24.11254. Proc Natl Acad Sci U S A. 1995. PMID: 7479975 Free PMC article.
Cited by
-
Mycobacterial drug discovery.RSC Med Chem. 2020 Nov 6;11(12):1354-1365. doi: 10.1039/d0md00261e. RSC Med Chem. 2020. PMID: 34085044 Free PMC article. Review.
-
Antimicrobial Peptides as Potential Anti-Tubercular Leads: A Concise Review.Pharmaceuticals (Basel). 2021 Apr 2;14(4):323. doi: 10.3390/ph14040323. Pharmaceuticals (Basel). 2021. PMID: 33918182 Free PMC article. Review.
-
Gallein and isoniazid act synergistically to attenuate Mycobacterium tuberculosis growth in human macrophages.bioRxiv [Preprint]. 2024 Jan 10:2024.01.10.574965. doi: 10.1101/2024.01.10.574965. bioRxiv. 2024. PMID: 38260681 Free PMC article. Preprint.
-
Mycobacterium tuberculosis DNA gyrase: interaction with quinolones and correlation with antimycobacterial drug activity.Antimicrob Agents Chemother. 2004 Apr;48(4):1281-8. doi: 10.1128/AAC.48.4.1281-1288.2004. Antimicrob Agents Chemother. 2004. PMID: 15047530 Free PMC article.
-
Identification of the polyketide synthase involved in the biosynthesis of the surface-exposed lipooligosaccharides in mycobacteria.J Bacteriol. 2009 Apr;191(8):2613-21. doi: 10.1128/JB.01235-08. Epub 2009 Jan 30. J Bacteriol. 2009. PMID: 19181796 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical